Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023
Yükleniyor...
Dosyalar
Tarih
2023
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
MDPI
Erişim Hakkı
Attribution 4.0 International
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
Özet
Periprosthetic joint infection (PJI) is a rare yet devastating complication following total joint arthroplasty (TJA). Early and accurate diagnosis of PJI is paramount in order to maximize the chances of successful treatment. However, we are yet to identify a single "gold standard" test for the diagnosis of PJI. As a result, the diagnosis of PJI is often challenging. Currently, the 2018 ICM definition of PJI is the only validated diagnostic criteria available. This article will review the importance of serum and synovial biomarkers in the diagnosis of PJI. In addition, it will provide a brief overview of the emerging modalities for the identification of infections in this setting.
Açıklama
Anahtar Kelimeler
Periprosthetic Joint Infection, Serum, Synovial Fluid, Marker
Kaynak
Antibiotics-Basel
WoS Q Değeri
Q1
Scopus Q Değeri
Q1
Cilt
12
Sayı
6
Künye
Yılmaz, M. K., Abbaszadeh, A., Tarabichi, S., Azboy, İ. ve Parvizi, J. (2023). Diagnosis of periprosthetic joint infection: The utility of biomarkers in 2023. Antibiotics-Basel, 12(6). https://dx.doi.org/10.3390/antibiotics12061054











